Pharmacy Report Archives - Page 9 of 148 - Becker's Hospital Review

10 drugs poised to be top sellers | FDA eyes changes to biosimilar approvals | Inside a Md. school's new PharmD curriculum | Cancer drug pulled from US market | Amazon Pharmacy to sell Zepbound KwikPen

March 10, 2026 1. 10 drugs expected to lead US sales in 2026 Full story 2. Maryland pharmacy school edits PharmD curriculum to target workforce demands Full story 3. When pharmacies disappear, patients pay the price. Learn how to fight back…

Novo, Hims reach GLP-1 truce | FDA, states review plans for Canada drug imports | Pa. hospitals lose CVS 340B case | FDA vaccine chief to exit in April | U of Kentucky taps 2 pharmacy leaders

Novo-Hims GLP-1 deal, CVS 340B ruling and FDA drug pricing push top today’s news March 9, 2026 1. Novo, Hims strike GLP-1 deal after legal feud Full story 2. FDA, states review plans to import drugs from Canada Full story…

Hospital drug prices vary widely: Report | Express Scripts to repay W.Va. pharmacies | 10 systems seeking pharmacy leaders | Feds uphold Hawaii 340B law | Novo inks $2.1B obesity drug deal

Hospital drug price gaps, Express Scripts repayment and 340B ruling top today’s news March 5, 2026 1. Hospital drug prices vary widely, advocacy tool shows Full story 2. Express Scripts to repay West Virginia pharmacies after state probe Full story…

FDA targets GLP-1 ads | AHA pushes back on Novo 340B proposal | Walgreens debuts hybrid pharmacist role | Judge blocks AbbVie in Tenn. 340B case

FDA GLP-1 warnings and 340B battles top today’s news March 4, 2026 1. FDA warns 30 telehealth firms over compounded GLP-1 claims Full story 2. AHA urges HHS to block Novo Nordisk's 340B data demand Full story 3. Procurement isn't…

Mount Sinai's pharmacy AI playbook | Hospitals gain Cost Plus Drugs pricing visibility | Minn. 340B revenue tops $1B | Miss. pharmacy program targets maternal health | FDA lifts hold on Intellia trial

Mount Sinai's AI push, 340B billions and FDA trial update top today’s news March 3, 2026 1. The question driving Mount Sinai's pharmacy AI strategy Full story 2. Cost Plus Drugs partners to give hospitals easier access Full story 3.…

What defines the next pharmacy chief | Cigna acquires CarepathRx | Feds back AbbVie 340B fight | CVS speeds specialty prior auths | RFK Jr. names 2 CDC vaccine panel members

Cigna’s pharmacy buy, 340B ruling and next-gen CPOs top today’s news March 2, 2026 1. What will define the next-generation chief pharmacy officer Full story 2. Cigna acquires hospital pharmacy company CarepathRx Full story 3. Drug costs rise, shortages persist…

Tariff ruling impacts drug imports: 3 notes | HRSA updates 340B rebate comment period | 10 systems hiring pharmacy leaders | FDA pauses drug trial after death | W.Va. school posts perfect pharmacy law exam results

340B delay, Supreme Court tariff ruling fallout and FDA trial pause lead today’s news February 26, 2026 1. HRSA extends comment period on 340B rebate proposal Full story 2. What the Supreme Court's tariff ruling means for drug imports: 3…

5 drug pricing disruptions to know | Trump calls for most-favored-nation law | Zepbound beats Novo GLP-1 in trial | WashU to acquire pharmacy school | 16 pharmacy leaders on '26 workforce crisis

5 drug pricing shifts to watch & Zepbound outperforms Novo GLP-1. February 25, 2026 1. Drug pricing in 2026: 5 forces reshaping pharmacy economics Full story 2. Zepbound beats Novo Nordisk's experimental GLP-1 in head-to-head trial Full story 3. How SSM…

Ozempic, Wegovy list prices to drop in 2027 | Top schools for 1st-time NAPLEX pass rates | Bayer sues J&J over cancer drug claims | CVS raises corporate bonuses | SSM navigates Medicaid shift with pharmacists

Wegovy list price to drop 50% in 2027, CVS raises corporate bonuses & Bayer sues J&J. February 24, 2026 1. Novo Nordisk to lower list price of Wegovy, Ozempic in 2027 Full story 2. Bayer sues J&J over prostate cancer drug…

Hospitals push to delay 340B rebate rollout | Lilly launches new Zepbound device | FDA opens ultra-rare drug pathway | La. reaches $45M settlement with CVS | Walgreens to cut 628 jobs

FDA rare-disease shift, new Zepbound launch and 340B pressure headline today’s news February 23, 2026 1. Hospitals urge HHS to extend comment deadline on 340B rebate pilot Full story 2. Eli Lilly launches new form of Zepbound Full story 3.…